✦ LIBER ✦

Fingolimod provides long-term protection in rodent models of cerebral ischemia

✍ Scribed by Ying Wei; Muge Yemisci; Hyung-Hwan Kim; Lai Ming Yung; Hwa Kyoung Shin; Seo-Kyoung Hwang; Shuzhen Guo; Tao Qin; Nafiseh Alsharif; Volker Brinkmann; James K Liao; Eng H Lo; Christian Waeber

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 986 KB
Volume: 69
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.22186

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term protection of brain tissue fro

Long-term protection of brain tissue from cerebral ischemia by peripherally administered peptidomimetic caspase inhibitors

✍ Thomas L. Deckwerth; Lisa M. Adams; Christoph Wiessner; Peter R. Allegrini; Mark 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

No barbiturate protection in a dog model

No barbiturate protection in a dog model of complete cerebral ischemia

✍ Petter A. Steen; James H. Milde; Dr. John D. Michenfelder 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 585 KB

## Abstract Complete global ischemia was produced in 39 dogs by temporary ligation of the aorta. Prior to the ischemic episode, pentobarbital (30 to 45 mg per kilogram of body weight) was administered to 19 of these dogs. The neurological effects of cerebral ischemia episodes lasting 8, 9, or 10 mi

Long-term effects of early-life environm

Long-term effects of early-life environmental manipulations in rodents and primates: Potential animal models in depression research

✍ Christopher R. Pryce; Daniela Rüedi-Bettschen; Andrea C. Dettling; Anna Weston; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Intravenous administration of glial cell

Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat

✍ Yoshifumi Horita; Osamu Honmou; Kuniaki Harada; Kiyohiro Houkin; Hirofumi Hamada 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

## Abstract Intravenous administration of human mesenchymal stem cells (hMSCs) prepared from adult bone marrow has been reported to ameliorate functional deficits after cerebral artery occlusion in rats. Several hypotheses to account for these therapeutic effects have been suggested, and current th